Register Login
Register to leave comments
  • News bot April 30, 2026, 8:04 p.m.

    📋 PACIRA BIOSCIENCES, INC. (PCRX) - Financial Results

    Filing Date: 2026-04-30

    Accepted: 2026-04-30 16:03:02

    Event Type: Financial Results

    Event Details:

    PACIRA BIOSCIENCES, INC. (PCRX) Reports the reporting period Financial Results PACIRA BIOSCIENCES, INC. (PCRX) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 177376
    • Net Income: 2916
    • EPS: Not disclosed
    • Cash and equivalents: 144306
      • Patient Enrollment Concluded in Phase 3 Registration Study Evaluating Safety and Efficacy of ZILRETTA for the Treatment of Shoulder Osteoarthritis. In April 2026, the company concluded patient enrollment in its Phase 3 registration study of ZILRETTA for osteoarthritis, or OA, pain of the shoulder. The company expects to report topline results later this year. If the study is successful, ZILRETTA could be the first product with an on
      • label indication for OA pain of the shoulder.
      • world EXPAREL Data Shows Lower Total Healthcare Costs in Outpatient THA and TKA Procedures. In April 2026, the company presented data from three real

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 36.78K 32.62K $4.16K +12.75%
    Intangible Assets Net 353.23K 368.10K $-14.87K -4.04%
    Current Liabilities Accounts Payable 14.01K 14.01K $0.00 +0.00%
    Operating Expenses Selling General Administrative 93.94K 86.78K $7.17K +8.26%
    Other Income Expense Interest Income 1.93K 6.89K $-4.96K -72.01%
    Other Income Expense Interest Expense -3.70K -4.58K $881.00 +19.24%
    Selling General And Administrative Reconciliation Selling General Administrative 93.94K 93.94K $0.00 +0.00%
    Selling General Administrative 83.88K 83.88K $0.00 +0.00%
    Interest Income -1.93K -6.89K $4.96K +72.01%
    Interest Expense 3.70K 4.58K $-881.00 -19.24%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: PACIRA BIOSCIENCES, INC.
    • Ticker Symbol: PCRX

Search

News categories